Compare VRE & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRE | ENOV |
|---|---|---|
| Founded | 1949 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Fluid Controls |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 1995 | 2008 |
| Metric | VRE | ENOV |
|---|---|---|
| Price | $19.00 | $24.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | $19.50 | ★ $47.38 |
| AVG Volume (30 Days) | 590.3K | ★ 1.1M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | ★ 420.00 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $288,434,000.00 | N/A |
| Revenue This Year | N/A | $6.36 |
| Revenue Next Year | $2.87 | $5.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 6.40 | N/A |
| 52 Week Low | $13.69 | $21.00 |
| 52 Week High | $19.03 | $36.82 |
| Indicator | VRE | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 67.08 | 47.60 |
| Support Level | $18.88 | $23.81 |
| Resistance Level | $19.01 | $27.11 |
| Average True Range (ATR) | 0.02 | 1.54 |
| MACD | -0.01 | -0.11 |
| Stochastic Oscillator | 92.86 | 22.83 |
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.